Chemo mouth is a common side effect of undergoing chemotherapy. Dr. Rajiv Saini of Texas discusses the symptoms, risks and ...
Funding from Cancer Prevention and Research Institute of Texas has brought more than 324 distinguished cancer researchers to Texas.
Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.
The registrational trial will include 212 patients who are newly diagnosed with advanced head and neck cancer.
The University of Texas MD Anderson Cancer Center today was awarded nearly $23 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of 20 cancer research projects to ...
Typically this would be spread out over a year, but thanks to advances in surgical precision and 3D printing, can be ...
"The more we study ... the more clearly we understand the risks." Experts call for increased action against concerning toxins ...
The University of Texas MD Anderson Cancer Center today was awarded nearly $23 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of 20 cancer research projects to ...
These beverages, packed with bioactive compounds, bring new hope in the fight against this disease, affecting thousands of ...
When Melissa Ames started having tooth pain, she went to the dentist. However, it wasn’t just a toothache from a cavity that ...
The doctor’s responsibility is to identify which patients are prone to infections and implement preventative measures early.
Cancer is an insidious disease, alarmingly shaping the global health crisis as it claims millions of lives each year.